Patients With Pretreated DME May Need More Frequent Aflibercept Injections

(MedPage Today) — Patients with prior treatment for diabetic macular edema (DME) may require more frequent dosing of aflibercept (Eylea), according to a subgroup analysis of the PHOTON trial presented at the recent Association for Research in…

Source link : https://www.medpagetoday.com/meetingcoverage/arvovideopearls/116039

Author :

Publish date : 2025-06-12 16:29:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

Patients With Pretreated DME May Need More Frequent Aflibercept Injections

The Vera Rubin Observatory is about to completely transform astronomy

More Data Back CAR T-Cell Therapy for Lupus, With Promise of Wider Availability

Related Posts

Not All Processed Foods Are Created Equal

What Was Trump Diagnosed With?

Suicidality in Older Adults; Opioid Use Disorder Treatment in Primary Care

Doctors in Elected Office Are Turning Their Backs on Science

When Systemic Therapy Is Delayed for Syphilitic Uveitis, Ceftazidime May Help

Monoclonal Antibodies May Stop Vertical HIV Transmission From Mom to Baby

Not All Processed Foods Are Created Equal

What Was Trump Diagnosed With?

Suicidality in Older Adults; Opioid Use Disorder Treatment in Primary Care

Doctors in Elected Office Are Turning Their Backs on Science

When Systemic Therapy Is Delayed for Syphilitic Uveitis, Ceftazidime May Help

Monoclonal Antibodies May Stop Vertical HIV Transmission From Mom to Baby

Premature babies in UK to be immunised against winter virus RSV

FDA Advisors Give PTSD Drug Combination a Thumbs Down

Categories

Archives